RETATRUTIDE 40mg

Retatrutide 40mg (LY3437943) is a synthetic investigational peptide studied as a triple agonist of the GIP, GLP-1 and glucagon receptors. It is supplied as a reference material for in-vitro receptor-binding, signalling and pharmacology research.

Specification

• Contents: 40mg per unit

• Format: lyophilised powder or pen cartridge (select above)

• Identity and purity: confirmed by HPLC and mass spectrometry, documented on the batch-specific Certificate of Analysis

• Manufactured in Switzerland under ISO 9001:2015 quality management

Storage

Store sealed, protected from light, at 2–8 °C. For long-term storage keep lyophilised material at −20 °C.

Research Use Only. Retatrutide is not an approved medicine. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease. Sold only to buyers who confirm laboratory research use.